HomeINM • NASDAQ
Follow
InMed Pharmaceuticals Inc
Previous close
$0.35
Day range
$0.34 - $0.38
Year range
$0.29 - $2.08
Market cap
2.21M USD
Avg Volume
228.00K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 1.24M | 163.99% |
Operating expense | 2.03M | -14.22% |
Net income | -1.48M | 29.65% |
Net profit margin | -119.19 | 73.35% |
Earnings per share | — | — |
EBITDA | -1.65M | 24.51% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 9.58M | -16.67% |
Total assets | 15.26M | -9.84% |
Total liabilities | 2.48M | -3.92% |
Total equity | 12.77M | — |
Shares outstanding | 6.06M | — |
Price to book | 0.15 | — |
Return on assets | -32.57% | — |
Return on capital | -35.80% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -1.48M | 29.65% |
Cash from operations | -1.85M | 31.88% |
Cash from investing | -9.29K | 98.14% |
Cash from financing | 4.65M | -12.44% |
Net change in cash | 2.80M | 33.04% |
Free cash flow | -1.35M | 44.68% |
About
Founded
1981
Headquarters
Website
Employees
13